Beijing Airdoc Technology Co., Ltd. (HKG:2251)

Market Cap	1.31B
Revenue (ttm)	160.39M
Net Income (ttm)	-193.55M
Shares Out	103.16M
EPS (ttm)	-1.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,200
Average Volume	92,365
Open	12.72
Previous Close	12.72
Day's Range	12.72 - 12.76
52-Week Range	10.00 - 16.00
Beta	0.75
RSI	33.64
Earnings Date	Nov 28, 2025

About Beijing Airdoc Technology

Beijing Airdoc Technology Co., Ltd. provides artificial intelligence (AI) empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally. The company offers a software as a medical device (SaMD) product, Airdoc-AIFUNDUS, which is an AI-assisted diagnosis of retinal detection product that is available in three versions comprising version 1.0 for the diagnosis of diabetic retinopathy, version 2.0 that address various fundus diseases, and version 3.0 for the diagnosis of pathological m...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 282
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2251

Financial Performance

In 2024, Beijing Airdoc Technology's revenue was 156.37 million, a decrease of -23.34% compared to the previous year's 203.96 million. Losses were -255.46 million, 92.8% more than in 2023.

Financial numbers in CNY